TapImmune Inc. Featured in the March 11 Issue of the Financial Hub, www.cpreports.com
March 16, 2011 15:57 ET
|
TapImmune Inc.
SEATTLE, March 16, 2011 (GLOBE NEWSWIRE) -- The article (http://www.cpreports.com/?p=931), written by respected business writer Gene Marcial, provides insights into recent progress of TapImmune Inc....
Status of Clinical Development Clarification
March 04, 2011 18:32 ET
|
TapImmune Inc.
SEATTLE, March 4, 2011 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), wishes to provide a clarification to the Press Release issued on March 1, 2011 'TapImmune Closes $1.16 Million Funding'.
We...
TapImmune Closes $1.16 Million Funding
March 01, 2011 09:56 ET
|
TapImmune Inc.
SEATTLE, March 1, 2011 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) is pleased to announce the closing of a $1.16M funding.
On February 24, 2011, we entered into a securities purchase agreement...
TapImmune Provides Corporate Update
October 14, 2010 08:45 ET
|
TapImmune Inc.
SEATTLE, Oct. 14, 2010 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV). Over the last 12 months we have made significant progress in moving TapImmune and its technology platform toward the clinic....
TapImmune Appoints New Personnel to Board of Directors and Advisory Team
September 08, 2010 09:15 ET
|
TapImmune Inc.
SEATTLE, Sept. 8, 2010 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) is pleased to announce the following appointment to its Board of Directors:
Lynn M. DePippo, Founder and Managing Partner,...
TapImmune Signs Research and Technology License Option Agreement for Smallpox Vaccine
August 04, 2010 09:00 ET
|
TapImmune Inc.
SEATTLE, Aug. 4, 2010 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) announced that it has signed a Research and Technology License Option Agreement with Mayo Clinic, Rochester, MN, for the...
TapImmune Executes a Licensing Option Agreement for a Breast Cancer Vaccine Technology
June 01, 2010 09:00 ET
|
TapImmune Inc.
BELLEVUE, Wash., June 1, 2010 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) announced that it has signed an exclusive Licensing Option agreement with Mayo Clinic, Rochester, MN, for clinical...
TapImmune Closes Institutional Financing Totaling $1.53 Million
May 24, 2010 14:44 ET
|
TapImmune Inc.
BELLEVUE, Wash., May 24, 2010 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) announced today that the Company has completed the sale of Senior Secured Convertible Notes ("Notes") totaling $1.53...
Tapimmune Inc. Executes a Securities Purchase Agreement for the Issuance of $1.53 Million in Convertible Debt
May 18, 2010 08:00 ET
|
TapImmune Inc.
BELLEVUE, Wash., May 18, 2010 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), a Nevada corporation, announced today that the Company entered into a definitive purchase agreement on May 17, 2010 with...
TapImmune Provides Shareholder Letter
February 23, 2010 07:00 ET
|
TapImmune Inc.
BELLEVUE, Wash., Feb. 23, 2010 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), is pleased to provide this corporate update to our shareholders and other interested parties.
With 2010 now out of the...